Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Meulenbeld HJ"'
Autor:
Meulenbeld HJ (AUTHOR), Peters W (AUTHOR), Meulenbeld, Hielke J1 (AUTHOR), Peters, Wim (AUTHOR)
Publikováno v:
New England Journal of Medicine. 11/6/2008, Vol. 359 Issue 19, pe23-e23. 1p.
Autor:
de Kruijff IE; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Van MN; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., van der Vlugt-Daane M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Hoop EO; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, 3045 PM Rotterdam, The Netherlands., Meulenbeld HJ; Department of Medical Oncology, Gelre Ziekenhuizen, 7334 DZ Apeldoorn, The Netherlands., Beeker A; Department of Medical Oncology, Spaarne Gasthuis, 2134 TM Hoofddorp, The Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Ziekenhuis, 5623 EJ Eindhoven, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands. j.martens@erasmusmc.nl., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Aug 20; Vol. 11 (8). Date of Electronic Publication: 2019 Aug 20.
Autor:
Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Cancer Genomics Netherlands, Rotterdam, The Netherlands., Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., De Laere B; GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Dirix LY; GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Meulenbeld HJ; Department of Internal Medicine, Gelre Ziekenhuizen, Zutphen, The Netherlands., Creemers GJ; Department of Internal Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands., van Weerden WM; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Jenster GW; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Nieuweboer AJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Cancer Genomics Netherlands, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2019 Aug; Vol. 13 (8), pp. 1795-1807. Date of Electronic Publication: 2019 Jun 28.
Autor:
Onstenk W; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands. Electronic address: w.onstenk@erasmusmc.nl., Sieuwerts AM; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Kraan J; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Van M; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Nieuweboer AJ; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Mathijssen RH; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Hamberg P; Sint Franciscus Gasthuis, Department of Internal Medicine, Rotterdam, The Netherlands., Meulenbeld HJ; Gelre Ziekenhuizen, Department of Internal Medicine, Zutphen, The Netherlands., De Laere B; GZA Hospitals Saint Augustinus, Wilrijk, Belgium; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Dirix LY; GZA Hospitals Saint Augustinus, Wilrijk, Belgium; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., van Soest RJ; Erasmus MC, Department of Urology, Rotterdam, The Netherlands., Lolkema MP; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Martens JW; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., van Weerden WM; Erasmus MC, Department of Urology, Rotterdam, The Netherlands., Jenster GW; Erasmus MC, Department of Urology, Rotterdam, The Netherlands., Foekens JA; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., de Wit R; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Sleijfer S; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands.
Publikováno v:
European urology [Eur Urol] 2015 Dec; Vol. 68 (6), pp. 939-45. Date of Electronic Publication: 2015 Jul 15.
Autor:
Meulenbeld HJ; Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3008 AE, Rotterdam, The Netherlands, hielkem@hotmail.com., de Bono JS, Tagawa ST, Whang YE, Li X, Heath KH, Zandvliet AS, Ebbinghaus SW, Hudes GR, de Wit R
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2013 Oct; Vol. 72 (4), pp. 909-16. Date of Electronic Publication: 2013 Aug 07.
Autor:
Gerritse FL; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands., Meulenbeld HJ, Roodhart JM, van der Velden AM, Blaisse RJ, Smilde TJ, Erjavec Z, de Wit R, Los M
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2013 Oct; Vol. 49 (15), pp. 3176-83. Date of Electronic Publication: 2013 Jul 09.
Autor:
Meulenbeld HJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. h.meulenbeld@erasmusmc.nl, Bleuse JP, Vinci EM, Raymond E, Vitali G, Santoro A, Dogliotti L, Berardi R, Cappuzzo F, Tagawa ST, Sternberg CN, Jannuzzo MG, Mariani M, Petroccione A, de Wit R
Publikováno v:
BJU international [BJU Int] 2013 Jan; Vol. 111 (1), pp. 44-52. Date of Electronic Publication: 2012 Aug 29.
Autor:
Meulenbeld HJ; Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. h.meulenbeld@erasmusmc.nl, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Fosså SD, Polee M, Gerritsen W, Dalesio O, de Wit R
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2012 Nov; Vol. 48 (16), pp. 2993-3000. Date of Electronic Publication: 2012 Jun 06.
Autor:
Meulenbeld HJ; Erasmus University Medical Center, Daniel den Hoed Cancer Center, Department of Medical Oncology, Groene Hilledijk 301, Rotterdam, the Netherlands. h.meulenbeld@erasmusmc.nl, Mathijssen RH, Verweij J, de Wit R, de Jonge MJ
Publikováno v:
Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2012 Mar; Vol. 21 (3), pp. 383-93. Date of Electronic Publication: 2012 Jan 13.
Autor:
Meulenbeld HJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands., Hamberg P, de Wit R
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2009 Sep; Vol. 45 Suppl 1, pp. 161-71.